Streptokinase suppository - Heber Biotec
Alternative Names: Proctokinase; rSK suppository - Heber BiotecLatest Information Update: 30 Oct 2021
Price :
$50 *
At a glance
- Originator Center for Genetic Engineering and Biotechnology
- Developer Center for Genetic Engineering and Biotechnology; Heber Biotec
- Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasmin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Haemorrhoids
Most Recent Events
- 31 Jul 2013 The Center for Genetic Engineering and Biotechnology and Heber Biotec complete the phase II THERESA-2 trial in Haemorrhoids in Cuba
- 20 Dec 2010 Phase-II clinical trials in Haemorrhoids in Cuba (Rectal)